Y
LIVE

Serial Number

97909021

Owner

Prodigy Biotech, Inc.

Attorney

Carissa L. Rodrigue

Filing Date

Apr 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Y Trademark

Serial Number: 97909021

Y is a trademark filed by Prodigy Biotech, Inc. on April 26, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Prodigy Biotech, Inc. (3 trademarks)

719 Bradford Terrace
West Chester, PA 19382

Entity Type: 03

Trademark Details

Filing Date

April 26, 2023

Registration Date

Not Registered

Published for Opposition

May 28, 2024

Goods & Services

Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; pharmaceutical preparations and substances for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 22, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 22, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 22, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 22, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 22, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 23, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 23, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 23, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 25, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2023 NWOS
NEW APPLICATION ENTERED
May 1, 2023 NWAP